Scopia Capital Management 13F holdings, Q3 2018
Holdings as of September 30, 2018 · filings on SEC EDGAR · latest filing →
Scopia Capital Management disclosed 36 US equity positions worth $4.9bn in its Q3 2018 13F filing. The largest position was FOREST CITY RLTY TR INC at 11.1% of the reported book, followed by S9Q and ITRI. Against the Q2 2018 filing, it opened 3 new positions, added to 10 and reduced 12 among the top 36 holdings.
What did Scopia Capital Management own in Q3 2018? Top 36 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2018 |
|---|---|---|---|---|---|---|---|
| 1 | FOREST CITY RLTY TR INC | 11.1% | $543.8m | 21,672,157 | -2% | reduced | |
| 2 | S9Q SPIRIT AEROSYSTEMS HLDGS INC | 10.0% | $491.5m | 5,361,113 | 6% | added | |
| 3 | ITRI ITRON INC | Technology | 7.1% | $346.7m | 5,400,168 | -2% | reduced |
| 4 | VST VISTRA ENERGY CORP | Utilities | 6.1% | $300.3m | 12,071,361 | 44% | added |
| 5 | HORIZON PHARMA PLC | 5.9% | $289.0m | 14,762,354 | 24% | added | |
| 6 | ZOGENIX INC | 5.4% | $263.2m | 5,306,514 | 51% | added | |
| 7 | JCI JOHNSON CTLS INTL PLC | Industrials | 5.3% | $261.8m | 7,478,853 | -0% | held |
| 8 | GWPH GW PHARMACEUTICALS PLC | 5.2% | $256.9m | 1,487,307 | -27% | reduced | |
| 9 | ARRIS INTL INC | 4.8% | $233.9m | 9,000,000 | 119% | added | |
| 10 | RETROPHIN INC | 3.8% | $187.3m | 6,519,425 | 0% | held | |
| 11 | JD JD COM INC | Consumer Cyclical | 3.8% | $186.4m | 7,143,928 | 41% | added |
| 12 | INVESTORS BANCORP INC NEW | 3.6% | $174.1m | 14,190,051 | 29% | added | |
| 13 | SPIRIT RLTY CAP INC NEW | 3.1% | $150.7m | 18,693,585 | -23% | reduced | |
| 14 | ACORDA THERAPEUTICS INC | 2.9% | $139.7m | 7,106,955 | -7% | reduced | |
| 15 | MALLINCKRODT PUB LTD CO | 2.8% | $138.5m | 4,724,581 | -38% | reduced | |
| 16 | W WAYFAIR INC | Consumer Cyclical | 2.7% | $131.8m | 892,600 | -58% | reduced |
| 17 | EQT EQT CORP | Energy | 2.1% | $105.0m | 2,373,631 | 27% | added |
| 18 | CNMD CONMED CORP | Healthcare | 1.9% | $95.4m | 1,204,851 | -30% | reduced |
| 19 | WEATHERFORD INTL PLC | 1.7% | $84.1m | 31,019,881 | 16% | added | |
| 20 | PTCT PTC THERAPEUTICS INC | Healthcare | 1.6% | $76.0m | 1,616,998 | -30% | reduced |
| 21 | ENTERCOM COMMUNICATIONS CORP | 1.3% | $62.8m | 7,950,651 | -23% | reduced | |
| 22 | THC TENET HEALTHCARE CORP | Healthcare | 1.1% | $52.8m | 1,856,285 | 0% | held |
| 23 | LA JOLLA PHARMACEUTICAL CO | 1.1% | $52.1m | 2,590,212 | 0% | held | |
| 24 | PROTHENA CORP PLC | 1.0% | $51.2m | 3,916,407 | 12% | added | |
| 25 | RETROPHIN INC | 1.0% | $49.4m | 48,000,000 | – | new | |
| 26 | Y MABS THERAPEUTICS INC | 0.9% | $42.2m | 1,587,566 | – | new | |
| 27 | AYI ACUITY BRANDS INC | Industrials | 0.6% | $29.2m | 185,930 | 0% | held |
| 28 | SPIRIT MTA REIT | 0.6% | $27.8m | 2,410,153 | -0% | held | |
| 29 | PLAINS GP HLDGS L P | 0.5% | $25.9m | 1,055,000 | -72% | reduced | |
| 30 | CONVERGEONE HLDGS INC | 0.3% | $14.4m | 1,551,828 | -23% | reduced | |
| 31 | FOSL FOSSIL GROUP INC | Consumer Cyclical | 0.2% | $9.2m | 395,925 | 0% | held |
| 32 | INTERCEPT PHARMACEUTICALS IN | 0.2% | $8.2m | 64,961 | 0% | held | |
| 33 | SF9 SANDERSON FARMS INC | 0.2% | $7.9m | 76,887 | 0% | held | |
| 34 | INFLARX NV | 0.1% | $7.0m | 205,080 | – | new | |
| 35 | MNKD MANNKIND CORP | Healthcare | 0.1% | $3.0m | 1,666,498 | 0% | held |
| 36 | AMSC AMERICAN SUPERCONDUCTOR CORP | Industrials | 0.0% | $136.0k | 19,610 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.